MX2007007288A - Desacilacion de lps en bacterias gram negativas. - Google Patents
Desacilacion de lps en bacterias gram negativas.Info
- Publication number
- MX2007007288A MX2007007288A MX2007007288A MX2007007288A MX2007007288A MX 2007007288 A MX2007007288 A MX 2007007288A MX 2007007288 A MX2007007288 A MX 2007007288A MX 2007007288 A MX2007007288 A MX 2007007288A MX 2007007288 A MX2007007288 A MX 2007007288A
- Authority
- MX
- Mexico
- Prior art keywords
- gram negative
- lps
- negative bacteria
- deacylation
- bordetella
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 2
- 230000020176 deacylation Effects 0.000 title 1
- 238000005947 deacylation reaction Methods 0.000 title 1
- 239000002158 endotoxin Substances 0.000 abstract 4
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 2
- 241000588779 Bordetella bronchiseptica Species 0.000 abstract 1
- 241000588780 Bordetella parapertussis Species 0.000 abstract 1
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04078445 | 2004-12-17 | ||
| PCT/NL2005/050081 WO2006065139A2 (en) | 2004-12-17 | 2005-12-16 | Deacylation of lps in gram negative bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007007288A true MX2007007288A (es) | 2008-02-25 |
Family
ID=34928754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007007288A MX2007007288A (es) | 2004-12-17 | 2005-12-16 | Desacilacion de lps en bacterias gram negativas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8048433B2 (enExample) |
| EP (1) | EP1828378B1 (enExample) |
| JP (1) | JP5378685B2 (enExample) |
| CN (1) | CN101203605B (enExample) |
| AU (1) | AU2005317304B2 (enExample) |
| BR (1) | BRPI0519923A8 (enExample) |
| CA (1) | CA2590906C (enExample) |
| DK (1) | DK1828378T3 (enExample) |
| ES (1) | ES2493440T3 (enExample) |
| MX (1) | MX2007007288A (enExample) |
| NO (1) | NO340331B1 (enExample) |
| NZ (1) | NZ555889A (enExample) |
| PL (1) | PL1828378T3 (enExample) |
| PT (1) | PT1828378E (enExample) |
| WO (1) | WO2006065139A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101801997B (zh) * | 2007-03-26 | 2016-06-01 | 由卫生福利和体育大臣代表的荷兰王国 | 基于lps糖基转移酶突变体的改进的抗百日咳博德特氏菌疫苗 |
| SG11201500573RA (en) | 2012-08-06 | 2015-02-27 | Glaxosmithkline Biolog Sa | Method for eliciting in infants an immune response against rsv and b. pertussis |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| WO2014196887A1 (ru) | 2013-06-04 | 2014-12-11 | Aparin Petr Gennadievich | Модифицированный липополисахарид эндотоксичных бактерий (варианты), комбинация модифицированных липополисахаридов (варианты) и включающие их вакцина (варианты) и фармацевтическая композиция (варианты) |
| US11052142B2 (en) | 2013-06-04 | 2021-07-06 | Petr G. Aparin | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) |
| SG11201600709TA (en) | 2013-08-05 | 2016-02-26 | Glaxosmithkline Biolog Sa | Combination immunogenic compositions |
| WO2015179270A2 (en) | 2014-05-19 | 2015-11-26 | Board Of Regents, The University Of Texas System | Combinatorial platform for the display of surface adjuvants and antigens |
| CN104388368B (zh) * | 2014-10-30 | 2017-02-15 | 四川农业大学 | 一株低内毒素大肠杆菌原核表达工程菌突变株及构建方法 |
| EP3408274A1 (en) * | 2016-01-28 | 2018-12-05 | De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport | Modified tetra-acylated neisserial lps |
| CN105567620B (zh) * | 2016-01-29 | 2019-03-19 | 江南大学 | 一株产减毒类脂A的Cronobacter sakazakii突变株及其应用 |
| CN105695540A (zh) * | 2016-03-18 | 2016-06-22 | 辽宁成大生物股份有限公司 | 一种革兰氏阴性菌胞壁抗原的制备方法 |
| CA3055757A1 (en) * | 2017-03-13 | 2018-09-20 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Bordetella vaccines comprising lps with reduced reactogenicity |
| WO2018213242A1 (en) * | 2017-05-15 | 2018-11-22 | University Of Maryland, Baltimore | Live salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof |
| KR102822764B1 (ko) * | 2017-12-04 | 2025-06-19 | 인트라백 비.브이. | 외막 소포의 생성을 위한 개선된 방법 |
| US20230183656A1 (en) * | 2020-05-14 | 2023-06-15 | Merck Patent Gmbh | Methods and compositions for purifying adeno associated virus particles or adenoviruses |
| US20250263447A1 (en) | 2020-09-04 | 2025-08-21 | Intravacc B.V. | Ompa mutations enhance omv production in bordetella pertussis |
| EP4169513A1 (en) | 2021-10-19 | 2023-04-26 | GlaxoSmithKline Biologicals S.A. | Adjuvant composition comprising sting agonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH650681A5 (en) * | 1981-08-14 | 1985-08-15 | Dso Pharmachim | Whooping cough vaccine |
| KR0168039B1 (ko) * | 1987-09-04 | 1999-01-15 | 로버트 디. 웨스트 | 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신 |
| EP0484621A3 (en) * | 1990-07-11 | 1992-08-26 | American Cyanamid Company | Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| DE69333467T2 (de) * | 1992-08-18 | 2005-01-20 | Dimminaco Ag | Bordetella bronchiseptica impfstoff |
| PT826001E (pt) * | 1995-05-04 | 2002-12-31 | Aventis Pasteur | Vacinas acelulares contra a tosse convulsa e metodos para a sua preparacao |
| US6887483B2 (en) | 1995-12-01 | 2005-05-03 | University Of Iowa Research Foundation | Non-toxic mutants of pathogenic gram-negative bacteria |
| AU743114B2 (en) * | 1997-04-01 | 2002-01-17 | Corixa Corporation | Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| CA2264970A1 (en) * | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| PT1127137E (pt) * | 1998-11-03 | 2007-12-28 | Staat Nl Verteg Door Min Welzi | Lps com toxicidade reduzida a partir de bactérias gramnegativas modificadas geneticamente |
| US6531131B1 (en) * | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
| AU2002307448A1 (en) * | 2001-04-20 | 2002-11-05 | President And Fellows Of Harvard College | Methods and compositions for the modulation of biofilm formation |
-
2005
- 2005-12-16 CN CN200580048420.6A patent/CN101203605B/zh not_active Expired - Fee Related
- 2005-12-16 JP JP2007546589A patent/JP5378685B2/ja not_active Expired - Fee Related
- 2005-12-16 PT PT58154675T patent/PT1828378E/pt unknown
- 2005-12-16 EP EP05815467.5A patent/EP1828378B1/en not_active Expired - Lifetime
- 2005-12-16 ES ES05815467.5T patent/ES2493440T3/es not_active Expired - Lifetime
- 2005-12-16 MX MX2007007288A patent/MX2007007288A/es active IP Right Grant
- 2005-12-16 DK DK05815467.5T patent/DK1828378T3/da active
- 2005-12-16 BR BRPI0519923A patent/BRPI0519923A8/pt not_active Application Discontinuation
- 2005-12-16 CA CA2590906A patent/CA2590906C/en not_active Expired - Fee Related
- 2005-12-16 US US11/722,034 patent/US8048433B2/en not_active Expired - Fee Related
- 2005-12-16 NZ NZ555889A patent/NZ555889A/en not_active IP Right Cessation
- 2005-12-16 AU AU2005317304A patent/AU2005317304B2/en not_active Ceased
- 2005-12-16 PL PL05815467T patent/PL1828378T3/pl unknown
- 2005-12-16 WO PCT/NL2005/050081 patent/WO2006065139A2/en not_active Ceased
-
2007
- 2007-06-18 NO NO20073088A patent/NO340331B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5378685B2 (ja) | 2013-12-25 |
| WO2006065139A3 (en) | 2006-10-19 |
| CA2590906A1 (en) | 2006-06-22 |
| AU2005317304B2 (en) | 2011-06-23 |
| EP1828378A2 (en) | 2007-09-05 |
| PL1828378T3 (pl) | 2014-10-31 |
| AU2005317304A1 (en) | 2006-06-22 |
| NO340331B1 (no) | 2017-04-03 |
| NZ555889A (en) | 2009-07-31 |
| CN101203605A (zh) | 2008-06-18 |
| BRPI0519923A2 (pt) | 2009-08-11 |
| US20080274145A1 (en) | 2008-11-06 |
| WO2006065139A2 (en) | 2006-06-22 |
| ES2493440T3 (es) | 2014-09-11 |
| NO20073088L (no) | 2007-09-17 |
| DK1828378T3 (da) | 2014-09-01 |
| PT1828378E (pt) | 2014-10-10 |
| EP1828378B1 (en) | 2014-06-11 |
| CN101203605B (zh) | 2016-01-27 |
| BRPI0519923A8 (pt) | 2018-01-23 |
| CA2590906C (en) | 2017-01-03 |
| US8048433B2 (en) | 2011-11-01 |
| JP2008523805A (ja) | 2008-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073088L (no) | Deacylering av LPS i gramnegative bakterier | |
| ECSP055725A (es) | Formulaciones nutricionales que contienen sustancias simbióticas | |
| EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
| PL372929A1 (en) | Composition having bacteristatic and bactericidal activity against bacterial spores and vegetative cells and process for treating foods therewith | |
| TW200640908A (en) | Chemical compounds | |
| MXPA06001821A (es) | Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma. | |
| UA85993C2 (ru) | Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего | |
| UA93384C2 (ru) | Способ получения стерилизированного порошкообразного панкреатина | |
| ATE400281T1 (de) | Vaginales lactobacillus-medikament | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| TW200514847A (en) | Lactic acid bacteria having mucosal immunopotentiation effect | |
| TR200200301T2 (tr) | Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler | |
| EP1567660A4 (en) | Merging fermented ginseng, lactose, yoghurt, and lactose used in the production of milk lactobacteria | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| NO20050701L (no) | 4-pyrrolidino-fenyl-benzyleter derivater | |
| TW200505875A (en) | Novel compounds | |
| WO2005016264A3 (en) | Diamine derivatives of quinone and uses thereof | |
| ZA200710362B (en) | Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use | |
| SE0300795D0 (sv) | Composition comprising iscom particles and live micro-organisms | |
| ATE491026T1 (de) | Ply-gbs-lysinmutanten | |
| MXJL05000046A (es) | Mediadores de transporte reverso de colesterol para el tratamiento de hipercolesterolemia. | |
| AU2001238332A1 (en) | Method of sterilizing articles | |
| MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
| WO2005037219A3 (en) | Disinfecting teat care compositions | |
| MY146444A (en) | Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights |